Sr. Brand Manager for Kisunla at Eli Lilly and Company

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, NeuroscienceIndustries

Requirements

Bachelor’s or Master’s in Marketing, Business, or Life Sciences
7+ years in pharma marketing with specialty drug launch experience
Strong scientific leadership, strategic thinking, and problem-solving skills (getting things done)
Innovative approach to challenges and ability to lead cross-functional teams
Business-proficient level of English; excellent communication skills
High business acumen and results orientation
Digital marketing and omnichannel expertise
Flexibility for travel and adaptability to evolving market needs

Responsibilities

Develop and execute Kisunla’s brand strategy across launch and lifecycle phases
Ensure robust launch readiness and cross-functional alignment
Build strong stakeholder relationships (HCPs, payers, advocacy groups)
Manage brand P&L, forecast revenue, and optimize resources
Ensure compliance with global and local regulations

Skills

pharma marketing

brand strategy

specialty drug launch

scientific leadership

cross-functional leadership

stakeholder management

P&L management

revenue forecasting

regulatory compliance

digital marketing

omnichannel marketing

B2B marketing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free